CA2078229A1 - Plant promoter - Google Patents

Plant promoter

Info

Publication number
CA2078229A1
CA2078229A1 CA 2078229 CA2078229A CA2078229A1 CA 2078229 A1 CA2078229 A1 CA 2078229A1 CA 2078229 CA2078229 CA 2078229 CA 2078229 A CA2078229 A CA 2078229A CA 2078229 A1 CA2078229 A1 CA 2078229A1
Authority
CA
Canada
Prior art keywords
promoter
gene
sequence
protein
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2078229
Other languages
French (fr)
Inventor
Julie C. Lloyd
Ulrik John
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TWYFORD SEEDS Ltd
Trouw (UK) Ltd
Ciba Geigy UK Ltd
Rhone Poulenc Rorer Ltd
Advanced Technologies Cambridge Ltd
Biotal Ltd
Imperial Chemical Industries Ltd
MicroBio Group Ltd
Bayer CropScience Ltd Great Britain
Unilever UK Central Resources Ltd
Nickerson International Seeds Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078229A1 publication Critical patent/CA2078229A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A plant promoter is provided, which was identified as a promoter for two proline-rich protein (PRP) genes. The promoter can be used to control the expression of genes in plant tissues.

Description

W O 91/13991 P(~r/~,B91/00397 ~`.~...;`:
1 ~n7(~22s PI~NT PROMOTER
The present invention relates to a plant promoter.
The major structural components of the plant cell wall in terms of quantity are polysaccharides, including 5 cellulose, hemicellulose and pectin polymers which in certain specialised cell types, e.g. vascular/epidermal cells, are complemented by further components whose presence is adapted to the functional role of the cell. The plant cell wall of dicotyledonous plants has also been shown to 10 contain two types of structural protein, the hydroxyproline-rich glycoproteins (HGRPs) and more recently a glycine-rich protein (GRPs) class. The HGRPs termed extensions have a characteristic S-P4 repeat structure, the - proline residues being hydroxylated and subsequently 15 glycosylated.
A wide range of proline-rich proteins have now been isolated from dicotyledonous plants. Many of these have been shown to have cell wall associations although the functions remain as yet undefined. It is likely that in 20 different cell types and in different species the PRPs present will vary.
The isolation of genomic and cDNA clones encoding PRPs has shown that this a class of proteins containing some structurally more diverse sequences. It has been found that - ~ 25 some of the genes encoding the PRPs display a highly ~; regulated pattern of expression at the messenger RNA level and are induced by wounding, fungal infection, auxin or during nodulation. More recently two reports have come out showing that the expression of specific PRP genes is 30 correlated with specific developmental events.
In contrast to the position for dicot plants, very little data has been accumulated in relation to PRPs from monocot species. Purification of an extensin-like protein from maize was reported and only low levels of 35 hydroxyproline-residues were found. Subsequent to this a highly repetetive PRP cDNA sequence from maize has been : ;, -"
,' ' ~, ' : . , ~ ,;.. . .
; : . . ,; . . .: . . .

WO91~13991 PCT/GB91/00397 ~ ?.~9 - 2 -published and mRNA expression studies have shown that highest levels are present in root tip and coleoptile. This protein shares a significant level of similarity with PRPs from dicot species with the exception that it contains a 5 high proportion of threonine residues.
We have now identified a promoter sequence for each of two proline-rich protein (PRP) genes. Accordingly, the present invention provides a promoter having the nucleotide sequence:
(a~ from -1369 to -49 upstream of the PRP140 gene, or (b) from -2316 to -12 upstream of the PRP378 gene;
the sequence optionally being modified by one or more base substitutions, insertions andjor deletions and/or by an 15 extension at either or each end provided that the thus-modified sequence is capable of acting as a promoter.
The invention also provides a DNA fragment - comprising such a promoter operably linked to a heterologous gene encoding a protein. Additionally provided 20 is a vector which comprises a heterologous gene encoding a protein under the control of a promoter as above such that the gene is capable of being expressed in a plant cell ; transformed with the vector. A suitable vector is one in which the promoter is fused directly to the 5'-end of the 25 gene. The vector may further contain a region which enables the gene and the promoter to be transferred to and stably integrated in a plant cell genome. The.vector is generally a plasmid.
Plant cells can be transformed with such a vector.
The invention therefore further provides plant cells which harbour a promoter as above operably linked to a heterologous gene encoding a protein. Transgenic plants may be regenerated from such plant cells. A transgenic plant can be obtained which harbours in its cells a promoter as 35 above operably linked to a heterologous gene encoding a ~ protein. Seed may be obtained from the transgenis plants.

.- ., .

, .
.

WO91/13991 PCT/GB91/00397 ~
' ~ 3 ~ 207 ~22 9 The invention further provides a method of producing a desired protein in a plant cell, which method comprises:
(i) transforming a plant cell with a vector according to the invention, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) culturing the transformed plant cell under conditions which allow expression of the protein.
The invention additionally provides a method of ` producing a transgenic plant capable of producing a desired protein, which method comprises:
(i) transforming a plant cell with a vector according to the invention, the protein encoded by the gene 15 under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
The desired proteins can be isolated from the :' 20 transformed plant cells obtained by the first method and from the plants obtained by the second method.
, The present promoter is composed of the seqiuence upstream of the wheat PRP140 gene from base -1369 to base -49 or of the wheat PRP378 gene from base -2316 to base -12, 25 base 1 being A of the ATG translational start codon for PRP.
The seqiuence of the PRP140 promoter can be deduced from , Figure 6. The sequence of the PRP378 promoter can be deduced from Figure 5.
The promoter may be obtained by preparing a genomic 30 library of wheat DNA, screening the library for the PRP140 or PRP378 gene and digesting the sequience upstream of the wheat PRP140 or PRP378 gene with appropriate restriction ' enzymes andtor exonucleases. There is a NspBII restriction ~ site at base -49 and a XbaI restriction site at base -136g ;~3 35 of the upstream sequence of the PRP140 gene. There is a NotI restriction site at base +72 and a HindIII site at base ~, "

:

.. .. .. . .. ; , ;- . ,,, ~ ..

: -, . .. ,. . .: "
: , . ::- . : : . .

W O 91/13991 PC~r/G B91/00397 ?"~ 4 -2316 of the sequence of the PRP378 gene.
Several plasmid vectors have been prepared which contain an upstream sequence of the wheat PRP140 or PRP378 gene comprising the promoter sequence. These vectors 5 include pIPKH-12/2.3, pXNot/1.45, pBIXN/1.3 and pHN/2.4. E.
coli MC 1022 harbouring these ~ectors were deposited at the National Collection of Industrial and Marine Bacteria, Aberdeen, GB on 9 November 1989 under accession numbers NCIMB 40223, NCIMB 40224, NCIMB 40225 and NCIMB 40226 10 respectively. pBIXN/1.3 was deposited under the designation pIPXN/1.3.
The PRP140 promoter may be released from pXNot/1.45 by digesting the plasmid with XbaI and NspBII. The PRP378 promoter may be released from pHN/2.4 by linearisation with 15 NotI-BstXI, incubation with a nuclease, religation of the plasmid population, selecting a plasmid with a deletion at its 3'-end to base-12 of the PRP 378 gene and digesting the plasmid with HindIII.
The promoter sequence may be modified by one or more base substitutions, insertions and/or deletions and/or by an extension at either or both ends. However, the ; modified promoter sequence must still be capable of acting as a promoter. Sequences from base -769 to base -49 of the upstream sequence of the wheat PRP140 gene, and shorter, 25 have been found not to be sufficient to direct expression of a protein at satisfactory levels. On the other hand, the sequence from base -961 to base -49 upstream of the wheat PRP140 gene does direct protein expression at a satisfactory level. Typically there is a degree of homology of at least 30 60% between a modified sequence and the unmodified natural sequence from base -1369 to base -49 upstream of the wheat PRP140 gene or from base -2316 to -12 upstream of the wheat PRP378 gene. The degree of homology may be at least 75%, at least 85% or at least 95%.
A longer sequence may be provided which extends ùpstream of ~ase -1369 of the PRP140 gene or of base -2316 . ~

,;
' .
, . , ,~. ... . . . - .... . .
. : - . . . :

` ' ' , ' ,' . ' , . . ' ': . ' ' ' . ' ' : : .. : ' _ 5 _ 207~22~
of tbe PRP378 gene, for example to another restriction site.
An extension upstream typically comprises the natural nucleotide sequence upstream of base -1369 of the PRPl40 gene or of base -2316 of the PRP378 gene. Such a longer 5 sequence may be obtained from a genomic library of wheat DNA
as above.
The upstream sequence if the wheat PRP 140 gene from base -961 to base -49 may also be modified by one or - more base substitutions, insertions and/or deletions and/or lO by an extension at either or both ends. Again, such a modified sequence must be capable of acting as a promoter.
There may be a degree of homology of at least 60%, for example at least 75%, at least 85% or at least 95%, between the unmodified and modified longer sequences.
lS A modified promoter sequence may be obtained by introducing changes into the natural promoter sequence.
This may be achieved by any appropriate technique, including restriction of the natural sequence with an endonuclease, insertion of linkers, use of an exonuclease and/or a 20 polymerase and site-directed mutagenesis. A shorter DNA
sequence therefore may be obtained by removing nucleotides from the 5'-terminus or the 3'-terminus of the natural ~' promoter sequence, for example using an exonuclease such as exonuclease III or BAL 3l.
Whether a modified sequence is capable of acting as a promoter may be readily ascertained. The modified - sequence is placed upstream of a protein coding sequence, ; such as the bacterial reporter gene ~-glucuronidase as in the Example. Tobacco leaf discs can then be transformed.
30 The protein expressed by the transformed cells are then assayed, in the case of ~-glucuronidase as described in Example l.
The promoter may be operably linked to a heterologous gene encoding a protein. The heterologous gene 35 may encode any protein it is desired to express. By "heterologous" is that the gene is not naturally operably .

.,~',' .
- . , - , . .. - . ~ ., .

: , " ~ .: : ; :

- .. ., .. . :

W O 91/13991 PC~r/GB91/00~97 ,3 ~ ~

linked to the promoter. The gene does not therefore encode PRP140 in the case where the promoter is derived from the upstream sequence of the PRP140 gene or PRP37~ in the case where the promoter is derived from the upstream sequence of 5 the PRP378 gene. The protein may additionally comprise a transit peptide sequence at its N-terminus, encoded within the heterologous gene sequence.
The promoter is typically used to control the expression of genes in plant tissues. The protein whose 10 expression is controlled by the promoter may be a protein encoded by a herbicide-resistance gene or a protein conferring biological control of pests or pathogens. The protein may therefore be an insecticidal protein, such as B.
thurinaiensis toxin, to give resistance to leaf-eating 15 insects. Other uses to which the promoter may be put are the production of viral coat proteins to protect against viral infection, the production of high value proteins such as pharmaceuticals and the production of proteins to alter taste or nutritive value of forage grasses, etc.
The promoter sequence may be fused directly to a heterologous gene or via a linker. The linker sequence may comprise an intron. Excluding the length of any intron sequence, the linker may be composed of up to 45 bases, for example up to 30 or up to 15 bases. The linker sequence may 25 comprise a sequence encoding a transit amino acid sequence, for example a transit sequence capable of directing a protein to a chosen subcellular locality such as the chloroplasts or mitochondria. The linker sequence may comprise a sequence having enhancer characteristics, to 30 boost expression levels.
DNA fragments and vectors can be prepared in which the promoter is operably linked to a heterologous gene. The fragments and vectors may be single or double stranded.
Plant cells can be transformed by way of ~uch fragment , ~ 35 directly or by way of such a vector. The vector - incorporates the heterologous gene under the control of the ~, s: ~:
; , - . :.

, . - , , :
- : :. : .
: : ..

~` 207~229 promoter. The vector contains regulatory elements capable of enabling the gene to be expressed in a plant cell transformed with the vector. Such regulatory elements include, besides the promoter, translational initiation 5 and/or termination sequences. The vector typically contains too a region which enables the chimaeric gene and associated regulatory control elements to be transferred to and stably integrated in the plant cell genome.
The vector is therefore typically provided with lO transcriptional regulatory sequences and/or, if not present at the 3'-end of the coding sequence of the gene, a stop codon. A DNA fragment may therefore also incorporate a terminator sequence and other sequences which are capable of enabling the gene to be expressed in plant cells. An 15 enhancer or other element able to increase or decrease levels of expression obtained in particular parts of a plant or under certain conditions may be provided in the DNA
fragment and/or vector. The vector is also typically provided with an antibiotic resistance gene which confers ; 20 resistance on transformed plant cells, allowing transformed cells, tissues and plants to be selected by growth on appropriate media containing the antibiotic.
Transformed cells are selected by growth in an appropriate medium. Plant tissue can therefore be obtained 25 comprising a plant cell which harbours the heterologous gene under the control of the promoter , for example in the plant cell genome. The gene is therefore expressible in the plant cell. Plants can then be regenerated which include the - heterologous gene and the promoter in their cells, for 30 example integrated in the plant cell genome, such that the gene can be expressed. The regenerated plants can be reproduced and, for example, seed obtained.
A preferred way of transforming a plant cell is to use Aarobacterium tumefaciens containing a vector comprising 35 the promoter operably linked to the heterologous gene. A
~` hybrid plasmid vector may therefore be employed which ~"'' .
, ........................................................................... .

t:`

:- : .. . . ~ :
~` ' , . . : . . ' ......... .. ' ' : ~
,: : .

.

WO91/13991 PCT/GB91/~0397 ~7~2~.~ 8 -comprises:
(a) the heterologous gene under the control of the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a 5 plant cell;
(b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome; and (c) a DNA sequence which enables this DNA to be transferred to the plant genome.
Typically the DNA to be integrated into the plant cell genome is delineated by the T-DNA border sequences of a Ti-plasmid. If only one border sequence is present, it is preferably the right border sequence. The DNA sequence which enables the DNA to be transferred to the plant cell 15 genome is generally the virulence (vir) region of a ; Ti-plasmid.
The heterologous gene and its transcriptional and translational control elements, including the promoter, can therefore be provided between the T-DNA borders of a i 20 Ti-plasmid. The plasmid may be a disarmed Ti-plasmid from which the genes for tumorigenicity have been deleted. The gene and its transcriptional and control elements, including - the promoter, can, however, be provided between T-DNA
borders in a binary vector in trans with a Ti-plasmid with a 25 v r region. Such a binary vector therefore comprises:
(a) the heterologous gene under the control of the promoter and other regulatory elements capable of enabling the gene to be expressed when integrated in the genome of a plant cell; and ~`~ 30 (b) at least one DNA sequence which delineates the DNA to be integrated into the plant genome.
Aqrobacterium tumefaciens, therefore, containing a hybrid plasmid vector or a binary vector in trans with a Ti-plasmid possessing a vir region can be used to transform 35 plant cells. Tissue explants such as stems or leaf discs may be inoculated with the bacterium. Alternatively, the ., .
i : .
, ~ :
~ ~.Y
i,~,..
~; -,, , ,, . :' ,. ;. ,' , ' ; .' . . ; , ', ,. ,~

~. .~ . . . . . . . . . .
.. . . . . . ; . : .. :.
. . . .. ~. .. . , . : . :
. ' . . , .. , . . .: ~ . . . , , .:

~ ~; 9 2a~2~

bacterium may be co-cultured with regenerating plant protoplasts. Plant protoplasts may also be transformed by direct introduction of DNA fragments which encode the heterologous gene and in which the promoter and appropriate 5 other transcriptional and translational control elements are present or of a vector incorporating such a fragment.
Direct introduction may be achieved using electroporation or polyethylene glycol, microinjection or particle bombardment.
Plant cells from monocotyledonous or dicotyledonous lO plants can be transformed according to the present invention. Monocotyledonous species include barley, wheat, maize and rice. Dicotyledonous species include tobacco, tomato, sunflower, petunia, cotton, sugarbeet, potato, lettuce, melon, soybean, canola (rapeseed) and poplars.
l5 Tissue cultures of transformed plant cells are propagated to regenerate differentiated transformed whole plants. The transformed plant cells may be cultured on a suitable medium, preferably a selectable growth medium. Plants may be regenerated from the resulting callus. Transgenic plants ; 20 are thereby obtained whose cells harbour the promoter operably linked to the heterologous gene, for example integrated in their genome. The gene is consequently ; expressible in the cells. Seed from the regenerated plants can be collected for future use.
25The following Examples illustrate the present invention. In the accompanying drawings:
Figure l shows the restriction map of the insert DNA of phage 3cX2;
Figure 2 shows the restriction map of the insert -~ 30 DNA of phage E3.2:
Figure 3 shows the sequence of the PRP 378 gene;
-~ Figure 4 shows the sequence of the PRP 140 gene;
Figure 5 shows the regulatory sequence upstream of the PRP 378 gene;
35Figure 6 shows the regulatory sequence upstream of the PRP 140 gene;
~ . .
~, :
: , - .. . .
. .
: ' ' , , . : ' . , .: :, ' :' .
': . . '. '.' ' ' .. , . ' WO9l/13991 PCT/GB91/00397 2~ 9 ` ~

Figure 7 shows the construction of pBIHN/2.4;
Figure 8 shows the construction of pBIXN/1.3;
Figure 9 shows the construction of pBID -234, -400, -540, -769 and -961 N;
Figure 10 shows the construction of pIPKH -6, -12 and -50/2.3;
Figure 11 shows the construction of pIPH-6/2.3;
Figure 12 shows the construction of pIP S-6/762 and pIP P-6/615;
Figure 13 shows the construction of pIPD-6/1839, 1510, 1289, 1023 and 816;
- Figure 14 shows the sequences of the fusion junctions of constructs based on BIN 19;
Figure 15 shows the sequences of the fusion 15 junctions of constructs based on pUCl9;
Figure 16 shows the results of Gus assays for the - PRP140 promoter deletions;
Figure 17 shows the results of Gus assays for the PRP 378 deletions; and Figure 18 shows the nucleotide sequence of the cDNA
'r' clone (WPRP1).

1. Isolation of PRP Genes The strategy e~ployed to isolate wheat PRP
promoters involved first constructing a genomic library of wheat DNA and then screening of this library using a cDNA
probe for a PRP gene.
`~ High molecular weight DNA was isolated from dark grown shoots of Triticum aestivum cv. Chinese Spring : .i ~, 30 (Lazarus et aI, Plant Nol. Biol. 5, 8-24, 1985). Conditions for partial digestion with Sau3A were established. DNA
., .
fragments of 18-25 kb were purified by size fractionation on , sucrose density gradients. Lambda Charon 35 (Loenen and Blattner, Gene 26, 171-179, 1983) vector DNA was prepared by 35 digestion with BamHI and purification on sucrose density gradients. Vector DNA (1.5 ~g) and wheat DNA (3.5 ~g) were ~, ,:

.. ! . , . , ' . ' ~ . ' ' ' . ' . ' . . . .. , . ' ..

.f ~
207~22~ ` ' ligated at high concentration (500 ng/~l) using T4 DNA
ligase and subseguently packaged ln vitro using commercially available extracts (Stratagene).
About 2.6 x 1o6 recombinants were plated onto the 5 host E. coli K803 and DNA lifts from the plaques taken onto nitrocellulose filters. The wheat PRP cDNA WPRPl (Reference Example) was random primer labelled using 32p dATP and used to probe the library lifts. Positively hybridizing plaques were purified to homogeneity by several rounds of screening lO and then DNA from these positive phage was purified by further analysis.
2. Characterization of the PRP Genes Restriction maps were made of the insert DNA of the ` positive phages 3cX2 (Fig. l) and E3.2 (Fig. 2~ and the 15 position and orientation of the PRP genes determined by hybridization studies. DNA fragments covering these regions were subcloned into the plasmid vector pUBSl, which is a pUCl9 derivative containing the polylinker region of the Bluescript plasmid of Stratagene (Raines et al, Nucl. Acids.
~ 20 Res. 16, 7931-7942, 1988). Overlapping sequence was ; obtained from these clones by Exonuclease III digestion and double-stranded dideoxy nucleotide sequence analysis. Data were assembled and analysed using the Staden packages. The extent of the sequence determined is indicated on Figs l and 25 2.
DNA seguence comparisons between the PRP 378 gene (Fig. 3~ and the cDNA probe used to i~olate it revealed a - few base differences which suggested that the gene copy ; isolated may represent an allele of the cloned mRNA. The ~ 30 PRP 140 gene (Fig. 4) is evidently a novel form of PRP.
; ~ 3. PRP Upstream_Seouences The regulatory sequence upstream of the PRP 378 and PRP 140 genes, including all of those used in the constructs ` described below, are given in Figs 5 and 6 respectively.
; ; 35 Restriction enzyme sites used during subsequent cloning ~ procedures are indicated and underlined. It was proposed ,, .
~::
' ,, , . ~ .
:
,. .. . . ..
, , .
, . . . .
.: . . . . . .

~ 12 -that these sequences would contain all of the promoter and other regulatory elements necessary to direct correct expression of protein coding sequences placed downstream under their control.
S In order to test this proposal and assess the usefulness of the PRP 378 and PRP 140 promoters in the context of plant transformation a series of constructs were prepared. In each case part of the PRP 378 or PRP 140 upstream regions was placed in front of the bacterial lO reporter gene ~-glucuronidase and the nopaline synthase terminator sequences in a suitable vector. For the PRP 378 promoter this was a high copy number pUCl9 based plasmid for transient expression in Zea mays protoplasts. For the PRP
140 promoter this was a BINl9 based vector suitable for 15 transformation into Nicotiana tabacum. In both cases this allows expression, controlled by the PRP promoters, to be detected by an enzyme assay for ~-glucuronidase (Gus) activity using a fluorogenic substrate in extracts from transformed plants or protoplasts.
20 (a) pIPPKGT and PBIpxGT
plPPKGT is the EcoRI/SalI insert of pRAJ275 (Jefferson, Plant. Mol. Biol. Reporter 5, 387-405, 1987) blunted with Klenow fragment of E. coli DNA polymerase I, ~-` and ligated into the Klenow blunted Asp718 site of 25 pUCPolyTer (the nopaline synthetase terminator fragment ; cloned as a SstI/EcoRI fragment into pUCl9). The corresponding BINl9 based plasmid is pBIPKGT. pIPPKGT and pBIPKGT can be obtained from each other.
(b) BINl9 Based Constructs (pBI series) 30 (i) Construction of the plasmid ~BIHN/2.4 containina 2318 bp of sequence 5' of the PRP 378 translation initiation codon and 24 amino acids of PRP 378 codinq sequence in a ' translational fusion to ~-alucuronidase (Fia. 7) A 2.4 Kb HindIII-NotI fragment of the PRP 378 gene J;~ 35 (Fig. l) was subcloned into the plasmid vector pUBSl to form - the plasmid pHN/2.4. pHN/2.4 was linearised with NotI and ~, :,, .

', .

, . , - - : . :

-;
3~1 PCT/GB91/00397 l3 - ~ ;
the site filled in using Klenow fragment of E. coli DNA
polymerase I. The insert was excised by digestion with HindIII and inserted into HindIII-SmaI digested pBIl0l.3 (Jefferson, Plant. Mol. Biol. Reporter 5, 387-405, 1987) to 5 form pBIHN/2.4. The fusion junction was checked by nucleotide sequencing and its sequence along with the predicted amino acid sequence is shown in Fig. 14.

(ii) Construction of the plasmid pBIXN/l.3. a transc~iptional fusion of 1321 bp of 5' n~on-coding sequence l0 from PRP 140 to e-glucuronidase (Fia. 8) A l.45 kb XbaI-NotI fragment of the PRP 140 gene (Fig. 2) was subcloned into the plasmid vector pUB51 to form pXNot/l.45. A l.3 kb fragment was excised by digestion with XbaI and NspBII (Fig. 8) and inserted into XbaI-SmaI
15 digested pBIPKGT to form pBIXN/l.3. The sequence of the fusion junction is shown in Fig. 14.

(iii) Construction of the plasmids pBID -234. -400, -540.
; -769 and -961 N representina deletion of the PRP 140 ~ ~romoter from its 5' end (Fi~. 9) ; 20 The plasmid pXNot/1.45 (Fig. 8) was linearised by digestion with XbaI-PstI. Incùbation with Exonuclease III
for various periods resulted in deletion of varied lengths .
of sequence from the XbaI end. Treatment with Nuclease SI
and the Klenow fragment of E. coli DNA polymerase enabled 25 the plasmid population to be religated as closed circles.
Nucleotide sequencing was employed to determine the extent of deletion from the XbaI end of a representative portion of the population.
On the basis of the information provided by 30 sequencing, plasmids with deletion to within 234, 400, 540, 769 and 961 nucleotides 5' of the translation initiation codon of PRP 140 were chosen for evaluation of promoter activity (Fig. 6). The 5 restriction fragments were excised ~ by digestion with HindIII and NspBII and inserted into ;. ~, . .
", ' ' . .
' ' . ' ' .' ' , ' , ' . .
' . . : ' " ,,.,.,;,.,~,;,. ':

WO91/13~1 PCT/GU91/~397 r. ~
~ 14 ~
HindIII-SmaI digested pBIPKGT to form pBID -234/ ~400t ~540 -769 and -961 N. In all 5 constructs the sequence of the fusion junction is identical to that of pBIXN/1.3 (Fig. 14 ) (c) pU&l~ Based Constructs f~IP series~
5 (i) Construction of the plasmids pIPKH -6. -12 and -50/2.3 xepresentina deletion of the PRP 378 promoter from its 3 end (~iq. 10) The plasmid pHN/2.4 (Fig. 7) was linearised by digestion with NotI-BstXI. Incubation with Exonuclease III
10 for various periods resulted in deletion of varied lengths of sequence from the NotI end. Treatment with Nuclease SI
and the Klenow fragment of E. coli DNA polymerase enabled the plasmid population to be religated as closed circles.
Nucleotide sequencing was employed to determine the extent 15 of deletion from the NotI end of a representative portion of - the population.
On the basis of the information provided by sequencing, plasmids pHD -6, -12, -50/2.3 with inserts which extended approximately 2.3 kb downstream from the HindII
20 sites to within 6, 12 and 50 nucleotides 5' of the translation initation codon of PRP 378 were chosen for evaluation of promoter activity (Fig. 5). ~he 3 respective plasmids were linearised by a partial SstI digestion and the overhang blunted with ~ung Bean Nuclease. The 3 inserts 25 were excised by digestion with HindIII and inserted into HindIII-SmaI digested pIPPKGT to form pIPKH -6, -12, -50/2.3. The sequences of the fusion junctions are shown in Fig. 15.
(ii) Construction of pIPH-6~2.3 (Fia. 11) This plasmid is similar to pIPKH-6/2.3 except that the full length PRP 378 promoter has been inserted into ~^ pBI201.1 (Jefferson, 1987) and has a different junction ; (Fig. 15) without a "Kozak" consensus initiating ATG.

` ; (iii) Construction of pIP S-6/762. P~6/615 re~resentin~
35 short forms of the PRP 378 promoter deleted from its 5' end . .
., .
- . . :: , '. . ' .' : :
,' , ~ ' ~
"
.
.

WO91/13~1 PCT/GB91/~397 f~;t~'`

2~78229 (Fig. 12) The plasmid pIPH-6/2.3 (Fig. 11) was linearised by PstI or partial SstI digestion and the overhang blunted with Mung Bean Nuclease. Inserts with respectively 762 and 615 5 nucleotides of the PRP 378 promoter in a cassette with the GUS gene and the NOS terminator were excised by digestion with EcoRI and inserted into EcoRI/SmaI digested pUC19. In both constructs the sequence of the fusion junction is identical to that of pIPH-6/2.3 (Fig. 15).
- 10 (iv) Construction of pIPD-6/1839, 1510. 1289, 1023, 816 representina lonaer forms of the PRP 378 ~romoter deleted from its 5' end (Fiq. 13) The plasmid pHN/2.4 (Fig. 7) was linearised by - digestion with HindIII-ApaI. Incubation with Exonuclease 15 III for various periods resulted in deletion of varied lengths of sequence from the HindIII end. Treatment with Nuclease SI and the Klenow fragment of E. coli DNA
polymerase enabled the plasmid population to be religated as closed circles. Nucleotide sequencing was employed to 20 determine the extent of deletion from the HindIII end of a , `~ representative portion of the population.
On the basis of information provided by sequencing plasmids pD-1839, -1510, -1289, -1023 and -816 N with inserts extending from 1839 to 816 nucleotides 5' of the 25 translation initiation codon of PRP 378 were digested with KpnI-SstII. The excised fragments were ligated with ;^ EcoRI-partial SstII digested pIPH-6/2.3 (providing the proximal portion of the PRP 378 promoter in conjunction with the GUS gene and the NOS terminator) which in turn was 30 ligated into EcoRI-KpnI digested pUCl9. Once again in all constructs the sequence of the fusion junction is identical to that of pIPH-6/2.3 (Fig. 15).
4. Introduction of PRP Promoter Fusions into Nicotiana Constructs were mobilised from Escheri~hia coli 35 MC1022 into Aarobacterium tumefaciens LBA4404 as described (Bevan, Nucl. Acids. Res. 12, 8711-8721, 1984). Leaf discs ..
.
. .

.
: . ' ' .
~.
.

,'. '' J ~

2 0 7 ~3 ~.t . .~ ~ -- 16 of Nicotiana tabacum var. Samsun were transformed as described (Horsch et al, Science 223, 496-498, 1984) and selected on shooting medium containing lO0 ~g/ml kanamycin.
Typically between 5 and 15 plants containing each construct 5 were regenerated and assayed.
5. ~-Glucuronidase Assay of Transformed Plants The activity of the PRP promoters in individual transformants was determined by measuring ~-glucuronidase activity in leaf extracts. Tissue extracts were prepared lO and analysed for fluorescence of the reaction p-oduct 4-methyl umbelliferone as described (Jefferson, l~987).
Reactions were usually incubated at 37C for 4 hours with aliquots sampled at 2 hour intervals. The protein concentration in each extract was measured to allow direct 15 comparisons to be made between them (using a Bio-Rad kit).
Results of assays on PRPl40 promoter derived constructs expression in nmol 4-methyl umbelliferone - produced/min/mg protein are shown in Fig. 16. Because of the variation commonly observed betwee~ individual - 20 tranformed plants it is difficult to ascertain whether dissection of the PRP 140 promoter from 1369 to 961 nucleotides in length leads to a significant loss of activity. However, it is clear that the 769 and 540 nucleotide forms have substantially less activity and that 25 the 400 and 234 nucleotide forms are effectively inactive.
6. Introduction of PRP 378 Promoter_Fusions into Protoplasts Derived from a Suspension Culture of Zea maYs Anther Cells The pUCl9 based constructs were assayed for 30 transient expression by Ca - PEG mediated transformation of ` Zea mays anther derived cell suspension (cell line Ba Tan ; Bai) protoplasts based on the method of Chen et al. (Chen, D.F., Tassie, A., Dale, P.J., Goldsbrough, A.P., Liang, W., Bevan, M.W., Flavell, R.B. and Xia, Z.A. (1988). In: Puite, 35 K.J., Dons, J.J.M., Huizing, H.J., Kool, A.J., Koornneef, M.
and Krens, F.A. (eds) Progress in Plant Protoplast Research.
.~
~, .
; . . . : -~- . ': ' ' : ,, . . . , '', ~ . . ' : ' .' . '. ' ' W091/139gl PCT/GB91/~397 " .", . . .
,., - 17 _ 2 0 7~2 ~9 Kluwer Academic Publishers, Dordrecht). Typically for each construct 3 replicates of 50 ~g of DNA and 1 x 106 protoplasts were performed. As controls protoplasts were also transformed with identical amounts of herring sperm DNA
5 and the plasmid CG20 carrying one copy of the 850 bp form of the cauliflower mosaic virus (CaMV) 35S promoter.
7. ~-Glucuronidase Assay of PEG mediated Transformed Zea ~ays Protoplasts Lysates of transformed protoplasts were assayed for 10 ~-glucuronidase in the same manner as that for transformed plants tJefferson, 1987). Expressing activity per 1 x 104 protoplasts allowed comparisons to be made between constructs tested in the same experiment.
Results of assays on PRP 378 promoter derived 15 constructs expressed in nmol 4-methyl umbelliferone produced/min/l x 104 protoplasts are shown in Table 1 and Fig. 17.
Table 1. Gus Assavs: PRP378 Promoter 3' Deletions Construct nMOL of 4-MU/min/1 x 104 ~roto~lasts 20 CG20 (Ca~V 35S) 3.59 + 2.96 (100%) Herring sperm DNA 0.0308 (0.858) pIPKH -6 /2.3 9.65 + O.63 (269) -12 11.92 + 4~22 (332) -50 4.73 + 0.66 (132) ,i The 2.3 kbp form of the PRP 378 promoter is significantly stronger than the 850 bp form of the CaMV35S promoter in ~aize protoplasts (Table 1). In addition it is sensitive to relatively short deletions from its 3' end. Thus ~- pIPKH-12/2.3, the construct that places the promoter in almost its native context (Fig. 15) with respect to the - initiating "ATG" of the GUS gene, exhibits highest levels of expression; whilst activity declines if, in effect, the promoter is moved (Fig. 15) further or closer to the ATG.
Figure 17 illustrates the effect of deletions from ,. : -, ~:
:,.

- , :..... , ,. . ~ .. , . -.:
.
, .. .
, ' . .. . . . .

WO91/l3~1 PCT/GB91/~397 a~. 9 5' end of the PRP 378 promoter. A deletion of 800 bp reduces activity to less than 60% of the full length form, and activity continues to decline with extent of deletion.
Although the full length form of the PRP 378 promoter in this experiment does not have the same level of activity with respect to CaMV 35S as those in Table 1, its fusion junction is different and the initiating ATG of the ~-glucuronidase gene does not have the ~Kozak~ consensus (Fig. 15).

REFERENCE EXAMPLE
A cDNA, designated WPRPl, encoding a wheat PRP has been isolated and sequenced. The WPRPl clone was detected whilst a wheat cDNA library was being screened using antibodies raised against chloroplastic fructose-1,5-bisphosphatase. Why this antibody should cross-react with the WPRPl clone is not known. The cDNA isolated initially was not full length (1.3 Kb). The complete sequenre came from a long~r cDNA obtained by rescreening the cDNA library using the shorter clone.
The complete nucleotide sequence of the cDNA clone (WPRPl) from wheat with its deduced amino acid sequence is shown in Figure 18. This 1548 bp cDNA contains the complete coding sequence of 1137 base pairs with 101 bp of 5' non-coding sequence and 310 bp of 3' non-coding sequence te~minating in a poly-adenylation tail.

The localisation of Gus expression in tissues of the transformed tobacco plants of Example 1.4 was ; investigated. Assays were conducted as described in Example 1.5 except that tissues other than leaf were also assayed. The results are shown in Table 2 below. The values shown are pmol/min/ug protein. The numbers in brackets refer to ranking of tissue expression level within each individual transformed plant. There are significant . . . ~ .
.
. - .: . ~, : . . . ~ .
. . ' ~ ' .. . . .

WO9l/13991 PCT/GB91/00397 - 19 - 2~ g levels of expression in all tissues. The levels of expression in petioles and stems compare favourably with CaMV 35S.

leaf petiole root stem PRP140: 961 37.93 (5) 102.75 (1) 18.82 (3) 16.96 (4) 410.38 (3)170.16 (1)5.29 (4) 63.87 (2) 66.28 (4)65.02 (1)5.65 (5) 30.53 (2) 1369217.22 (3)95.45 (1)3.29 (5) 51.86 (2) 54.58 (3)104.64 (1)2.04 (5) 24.52 (2) 816.60 (3)305.35 (1)7.32 (5) 40.87 (2) 126.64 (5)76.25 (1)6.65 (4) 33.20 (2) CaMV 39.96 (4)58.25 (2)50.14 (3) 62.43 (1) BIN(0) 0.35 1.31 3.62 0.67 apical PRP140: 961 319.55 (2) - 4 1.96 ~5) ; 6 9.08 (3) 1369 2 17.21 (4) 54.31 (4) ; 826.70 (4) 1212.41 (3) CaMV 32.48 (5) BIN(O) 0.32 :, ,~ .,, , ~ ~

. , . , : .. -,: -.,, .. . . ~ . . . .

. . . . . .. . .

Claims (14)

- 20 -
1. A promoter having the nucleotide sequence:
(a) from -1369 to -49 upstream of the PRP140 gene, or (b) from -2316 to -12 upstream of the PRP 378 gene;
the sequence optionally being modified by one or more base substitutions, insertions and/or deletions and/or by an extension at either or each end provided that the thus-modified sequence is capable of acting as a promoter.
2. A promoter according to claim 1, having a sequence from -961 to -49 upstream of the PRP140 gene, optionally modified as specified in claim 1.
3. A DNA fragment comprising a promoter as claimed in claim 1 or 2 operably linked to a heterologous gene encoding a protein.
4. A vector which comprises a heterologous gene, encoding a protein, under the control of a promoter as claimed in claim 1 or 2, such that the gene is capable of being expressed in a plant cell transformed with the vector.
5. A vector according to claim 4, wherein the promoter is fused directly to the 5'-end of the said gene.
6. A vector according to claim 4 or 5, which further contains a region which enables the gene and the promoter to be transferred to and stably integrated in a plant cell genome.
7. A vector according to any one of claims 4 to 6, which is a plasmid.
8. A plant cell which has been transformed with a vector as claimed in any one of claims 4 to 7.
9. A plant cell which harbours a promoter as claimed in claim 1 or 2 operably linked to a heterologous gene encoding a protein.
10. A transgenic plant which has been regenerated from plant cells as claimed in claim 8 or 9.
11. A transgenic plant which harbours in its cells a promoter as claimed in claim 1 or 2 operably linked to a heterologous gene encoding a protein.
12. Seed obtained from a transgenic plant as claimed in claim 10 or 11.
13. A method of producing a desired protein in a plant cell, which method comprises:
(i) transforming a plant cell with a vector as claimed in any one of claims 4 to 7, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) culturing the transformed plant cell under conditions which allow expression of the protein.
14. A method of producing a transgenic plant capable of producing a desired protein, which method comprises:
(i) transforming a plant cell with a vector as claimed in any one of claims 4 to 7, the protein encoded by the gene under the control of the said promoter being the desired protein; and (ii) regenerating plants from the transformed cells.
CA 2078229 1990-03-14 1991-03-14 Plant promoter Abandoned CA2078229A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909005772A GB9005772D0 (en) 1990-03-14 1990-03-14 Plant promoter
GB9005772.0 1990-03-14

Publications (1)

Publication Number Publication Date
CA2078229A1 true CA2078229A1 (en) 1991-09-15

Family

ID=10672630

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2078229 Abandoned CA2078229A1 (en) 1990-03-14 1991-03-14 Plant promoter

Country Status (5)

Country Link
EP (1) EP0521915A1 (en)
JP (1) JPH07501682A (en)
CA (1) CA2078229A1 (en)
GB (1) GB9005772D0 (en)
WO (1) WO1991013991A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744134B1 (en) * 1996-01-29 1998-04-03 Biocem RESERVE PROTEINS FROM PLANTS ENRICHED IN AMINO ACIDS, IN PARTICULAR ALPHA-ZEIN BUT ENRICHED IN LYSINE PLANTS EXPRESSING SUCH PROTEINS
US7122721B1 (en) 1999-10-05 2006-10-17 Basf Aktiengesellschaft Plant gene expression under the control of constitutive plant V-ATPase promoters
US6479636B1 (en) 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US8022272B2 (en) 2001-07-13 2011-09-20 Sungene Gmbh & Co. Kgaa Expression cassettes for transgenic expression of nucleic acids
US7456335B2 (en) 2001-09-03 2008-11-25 Basf Plant Science Gmbh Nucleic acid sequences and their use in methods for achieving pathogen resistance in plants
DE10212892A1 (en) 2002-03-20 2003-10-09 Basf Plant Science Gmbh Constructs and methods for regulating gene expression
CA2484001A1 (en) 2002-05-08 2003-11-20 Basf Plant Science Gmbh Methods for increasing oil content in plants
DE10224889A1 (en) 2002-06-04 2003-12-18 Metanomics Gmbh & Co Kgaa Process for the stable expression of nucleic acids in transgenic plants
ATE546539T1 (en) 2002-07-26 2012-03-15 Basf Plant Science Gmbh REVERSING THE NEGATIVE-SELECTIVE EFFECT OF NEGATIVE MARKER PROTEINS AS A SELECTION METHOD
CA2534894C (en) 2003-08-11 2020-01-21 Kweek-En Researchbedrijf Agrico B.V. Fungus resistant plants and their uses
AU2004295427A1 (en) 2003-12-02 2005-06-16 Basf Aktiengesellschaft 2-methyl-6-solanylbenzoquinone methyltransferase as target for herbicides
EP1736543B1 (en) 2004-04-09 2011-10-26 Nisshin Seifun Group Inc. Method of detecting and quantifying wheat endogenous dna sequence
AU2005268917B2 (en) 2004-08-02 2010-05-20 Basf Plant Science Gmbh Method for isolation of transcription termination sequences
US9085774B2 (en) 2005-04-19 2015-07-21 Basf Plant Science Gmbh Methods controlling gene expression
US7994399B2 (en) 2005-06-23 2011-08-09 Basf Plant Science Gmbh Methods for the production of stably transformed, fertile Zea mays plants
CN1328385C (en) * 2005-07-15 2007-07-25 南开大学 High affinity ammonium transport factor fuse gene and its use in transgenic plant
EP1931789B1 (en) 2005-09-20 2016-05-04 BASF Plant Science GmbH Methods for controlling gene expression using ta-siran
EP1948806A2 (en) 2005-11-08 2008-07-30 BASF Plant Science GmbH Use of armadillo repeat (arm1) polynucleotides for obtaining pathogen resistance in plants
CA2632872A1 (en) 2006-01-12 2007-07-19 Basf Plant Science Gmbh Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants
JP5100644B2 (en) * 2006-05-15 2012-12-19 株式会社日清製粉グループ本社 Methods for detecting and quantifying endogenous wheat DNA and determining the contamination rate of genetically modified wheat in the test sample
EP2059600B1 (en) 2006-08-30 2014-04-02 BASF Plant Science GmbH Method for increasing resistance to pathogens in transgenic plants
WO2008043826A1 (en) 2006-10-12 2008-04-17 Basf Plant Science Gmbh Method for increasing pathogen resistance in transgenic plants
CA2663959A1 (en) 2006-10-13 2008-04-17 Basf Plant Science Gmbh Plants with increased yield
WO2008087141A2 (en) 2007-01-15 2008-07-24 Basf Plant Science Gmbh Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants
AR069573A1 (en) * 2007-12-05 2010-02-03 Monsanto Technology Llc PROMOTERS OF CHEMICAL AND RICH PROTEINS IN PROLINA FOR EXPRESSION IN PLANTS, WHERE THE PHENOTYPE IS A LOWER INFECTION WITH PATHOGENS
EP2199399A1 (en) 2008-12-17 2010-06-23 BASF Plant Science GmbH Production of ketocarotenoids in plants
JP5917788B2 (en) 2009-12-21 2016-05-18 国立研究開発法人農業・食品産業技術総合研究機構 Method for detecting and quantifying endogenous genes in wheat
EP2612918A1 (en) 2012-01-06 2013-07-10 BASF Plant Science Company GmbH In planta recombination

Also Published As

Publication number Publication date
EP0521915A1 (en) 1993-01-13
WO1991013991A1 (en) 1991-09-19
GB9005772D0 (en) 1990-05-09
JPH07501682A (en) 1995-02-23

Similar Documents

Publication Publication Date Title
CA2078229A1 (en) Plant promoter
US5905186A (en) Chimeric plant genes based on upstream regulatory elements of helianthinin
US5635618A (en) Promoter elements of chimeric genes of α-tubulin
US5633363A (en) Root preferential promoter
US6239329B1 (en) Shoot meristem specific promoter sequences
Fobert et al. Detection of gene regulatory signals in plants revealed by T-DNA-mediated fusions
AU4017801A (en) Seed-preferred promoter from maize
EP0914454B1 (en) A synthetic plant core promoter and upstream regulatory element
US5658773A (en) Tomato acid invertase gene
JPH05276951A (en) New plant promoter
WO2002078438A2 (en) Tissue-preferred promoter from maize
US5723757A (en) Plant promoters specific for sink organ expression of genes
EP0494215A1 (en) Light-activatable plant promoter
US7557264B2 (en) Gossypium hirsutum tissue-specific promoters and their use
US6437221B1 (en) Gene promoter sequences and uses thereof
US6664384B1 (en) Duplicated cassava vein mosaic virus enhancers and uses thereof
US5824865A (en) Chimeric plant genes based on upstream regulatory elements of helianthinin
JP2004534535A (en) New plant promoter
CA2389759A1 (en) Seed-preferred promoter from barley

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19950914